Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoichiro Natori

Showing results (31-40 of 73) with videos related to

Pageof 8
Sort By:
Scandinavian Journal of Immunology|March 5, 2024
Comparison of BNT162b2 and mRNA1273 vaccines in solid organ transplant recipients: Post-Hoc analysis of a Japanese national prospective studyMikiko Yoshikawa, Yoichiro Natori, Rikako Oki, et al.
Transplantation|March 12, 2025
Phase 2, Randomized, Double-blind, Placebo-controlled Study of Fiztasovimab (NPC-21) for Kidney Transplant Recipients at High Risk of Cytomegalovirus Infection (LionHeart21)Naotsugu Ichimaru, Yoichiro Natori, Rita R Alloway, et al.
Kidney International Reports|December 18, 2019
Pretransplant Levels of C-Reactive Protein, Soluble TNF Receptor-1, and CD38+HLADR+ CD8 T Cells Predict Risk of Allograft Rejection in HIV+ Kidney Transplant RecipientsJose F Camargo, Suresh Pallikkuth, Ilona Moroz, et al.
Infection Control and Hospital Epidemiology|July 12, 2017
Surgical Site Infections After Liver Transplantation: Prospective Surveillance and Evaluation of 250 Transplant Recipients in CanadaYoichiro Natori, Rawan Kassar, Aled Iaboni, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|March 26, 2022
Reinfection with SARS-CoV-2 in solid-organ transplant recipients: Incidence density and convalescent immunity prior to reinfectionStephen Morris, Shweta Anjan, Suresh Pallikkuth, et al.
Open Forum Infectious Diseases|July 20, 2022
<i>Mycobacterium abscessus</i> Infections in Solid Organ Transplant Recipients: Single-Center Experience in the United States, 2013-2018Yosuke Ebisu, Yoichiro Natori, Gemma Rosello, et al.
Infection Control and Hospital Epidemiology|July 14, 2018
Risk factors for surgical site infection after kidney and pancreas transplantationYoichiro Natori, Salma Albahrani, Mohammed Alabdulla, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|January 27, 2023
Early administration of SARS-CoV-2 monoclonal antibody reduces the risk of mortality in hematologic malignancy and hematopoietic cell transplant patients with COVID-19Ra'ed Jabr, Akshay Khatri, Anthony D Anderson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 12, 2017
Use of Viral Load as a Surrogate Marker in Clinical Studies of Cytomegalovirus in Solid Organ Transplantation: A Systematic Review and Meta-analysisYoichiro Natori, Ali Alghamdi, Mahmood Tazari, et al.
Blood Advances|September 29, 2020
Reduced immunogenicity of the adjuvanted recombinant zoster vaccine after hematopoietic cell transplant: a pilot studyJose F Camargo, Rick Y Lin, Yoichiro Natori, et al.
Pageof 8

Showing results (31-40 of 73) with videos related to

Sort By:
Pageof 8
Scandinavian Journal of Immunology|March 5, 2024
Comparison of BNT162b2 and mRNA1273 vaccines in solid organ transplant recipients: Post-Hoc analysis of a Japanese national prospective studyMikiko Yoshikawa, Yoichiro Natori, Rikako Oki, et al.
Transplantation|March 12, 2025
Phase 2, Randomized, Double-blind, Placebo-controlled Study of Fiztasovimab (NPC-21) for Kidney Transplant Recipients at High Risk of Cytomegalovirus Infection (LionHeart21)Naotsugu Ichimaru, Yoichiro Natori, Rita R Alloway, et al.
Kidney International Reports|December 18, 2019
Pretransplant Levels of C-Reactive Protein, Soluble TNF Receptor-1, and CD38+HLADR+ CD8 T Cells Predict Risk of Allograft Rejection in HIV+ Kidney Transplant RecipientsJose F Camargo, Suresh Pallikkuth, Ilona Moroz, et al.
Infection Control and Hospital Epidemiology|July 12, 2017
Surgical Site Infections After Liver Transplantation: Prospective Surveillance and Evaluation of 250 Transplant Recipients in CanadaYoichiro Natori, Rawan Kassar, Aled Iaboni, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|March 26, 2022
Reinfection with SARS-CoV-2 in solid-organ transplant recipients: Incidence density and convalescent immunity prior to reinfectionStephen Morris, Shweta Anjan, Suresh Pallikkuth, et al.
Open Forum Infectious Diseases|July 20, 2022
<i>Mycobacterium abscessus</i> Infections in Solid Organ Transplant Recipients: Single-Center Experience in the United States, 2013-2018Yosuke Ebisu, Yoichiro Natori, Gemma Rosello, et al.
Infection Control and Hospital Epidemiology|July 14, 2018
Risk factors for surgical site infection after kidney and pancreas transplantationYoichiro Natori, Salma Albahrani, Mohammed Alabdulla, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|January 27, 2023
Early administration of SARS-CoV-2 monoclonal antibody reduces the risk of mortality in hematologic malignancy and hematopoietic cell transplant patients with COVID-19Ra'ed Jabr, Akshay Khatri, Anthony D Anderson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 12, 2017
Use of Viral Load as a Surrogate Marker in Clinical Studies of Cytomegalovirus in Solid Organ Transplantation: A Systematic Review and Meta-analysisYoichiro Natori, Ali Alghamdi, Mahmood Tazari, et al.
Blood Advances|September 29, 2020
Reduced immunogenicity of the adjuvanted recombinant zoster vaccine after hematopoietic cell transplant: a pilot studyJose F Camargo, Rick Y Lin, Yoichiro Natori, et al.
Pageof 8